● VerifiedLast verified 2026-04-13
DNA Funded
TradeLocker + TradingView, 90% split, scaling to $600K
· Specification
The full spec.
Execution
- Venue
- cfd
- Exchange
- TRADELOCKER, MT5-SYNTHETIC
- Platforms
- TradeLocker · TradingView · MT5
- Pairs
- 20+
- Leverage (majors)
- 5×
- Leverage (alts)
- 3×
Challenge
- Types
- 1-step · 2-step
- Profit target
- 10%
- Daily drawdown
- 5%
- Max drawdown
- 10%
- Drawdown type
- trailing
- Account sizes
- $5.0K – $200K
- Max scaling
- $600K
Economics
- Profit split
- 80–90%
- Payout methods
- USDT · USDC · Bank · Wise
- Payout speed
- 24h
- Payout frequency
- on-demand
- KYC required
- Yes
Features
- Weekend hold
- Allowed
- Overnight hold
- Allowed
- News trading
- Allowed
- Copy trading
- Allowed
- EAs / bots
- Allowed
- Scaling plan
- Yes
- Swap-free
- Yes
▲ Pros
- ▲TradingView native integration (rare in prop firms)
- ▲Up to $600K scaling cap
- ▲EAs and copy trading permitted
- ▲Multi-platform: TradeLocker + MT5 + TradingView
▼ Cons
- ▼Crypto is CFD-synthetic only — no real exchange execution
- ▼Limited crypto pair universe (~20)
- ▼Lower leverage tiers on crypto
· Editorial
Our take.
DNA Funded is a 2024-vintage prop firm running TradeLocker + MT5 + TradingView with scaling up to $600K. Crypto is handled as CFDs across ~20 pairs with conservative leverage. The appeal is platform flexibility and a generous scaling plan — not crypto-native depth.
· Frequently asked
Questions traders ask.
What's TradeLocker and why does DNA Funded use it?
+
TradeLocker is a modern web-based platform that competes with MT5 and cTrader. Its UI is cleaner and mobile-first, which is why a number of 2024+ prop firms — including DNA Funded — adopted it. Execution is still CFD-synthetic.
Ready to trade DNA Funded?
10% OFF Challenge via cryptopropfirmmatch.com. Your code is applied automatically at checkout.